The primary focus of the Junior Regulatory Affairs Specialist role is to manage lifecycle activities for mature products and contribute to the development and registration of new products, in compliance with Korean regulatory requirements, Servier Group standards, SOPs, and OPMs.
This position reports to Head of Regulatory Affairs & Quality.
The Junior Regulatory Affairs Specialist is responsible for assigned regulatory affairs activities across product development, registration, and lifecycle management, under the supervision of the Head of Regulatory Affairs and Quality:
For marketed products, the Junior Regulatory Affairs Specialist, in collaboration with WRA, is responsible for:
The Junior Regulatory Affairs Specialist is the primary point of contact for all interactions with the MFDS, including inspections (GMP, GCP), within the scope of his/her responsibilities as assigned by the Head of Regulatory Affairs and Quality.
The Junior Regulatory Affairs Specialist is responsible for maintaining awareness of current legislation in Korea and advising WRA and the Clinical Operations Department in Korea on changes in pharmaceutical legislation and regulatory authority requirements.
The Junior Regulatory Affairs Specialist is responsible for maintaining regulatory affairs documents, including SOPs and OPMs.
The Junior Regulatory Affairs Specialist is responsible for performing other related duties and special projects as assigned by the Head of Regulatory Affairs and Quality.

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
--
To report a suspected adverse event with a Servier drug, please visit servier.com